New York, New York (PRWEB) September 05, 2013
Biomet hip lawsuit (http://www.consumerinjurylawyers.com/biomet-magnum-hip-replacement) claims involving the M2a Magnum Hip Replacement System continue to move forward in a federal multidistrict litigation now underway in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to an Order and Stipulation issued by the Court on September 3rd, the parties in one Biomet hip replacement claim pending in the proceeding have agreed to remand the case to Indiana’s St. Joseph County Circuit Court, where it was originally filed. The Order notes that Biomet hip lawsuits involving the M2a Magnum hip that have been filed in the state of Indiana are being transferred to St. Joseph County Circuit Court for consolidation, as per agreement of the parties and the State Court. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“Our Firm is actively representing Biomet hip replacement patients in the federal litigation, and we continue to receive inquiries from M2a Magnum hip recipients who have suffered serious complications, allegedly due to the metal-on-metal design of the device. Our clients' experiences very much echo the allegations put forth in this particular Biomet hip replacement claim,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is offering free and confidential Biomet hip lawsuit evaluations to individuals who may have been injured by an M2a Magnum hip.
Biomet Hip Replacement Lawsuits
Nearly 600 Biomet hip replacement claims have been filed in the federal litigation underway in Indiana on behalf of M2a Magnum recipients who have suffered metallosis, chronic pain, hip failure and other debilitating injuries due to its allegedly defective design. Plaintiffs claim the M2a Magnum hip can shed dangerous amounts of metal debris due to wear of its metal components, which can lead to painful and serious complications that necessitate risky surgery to replace the device.
The U.S. Food & Drug Administration (FDA) has been investigating metal-on-metal hips, like the Biomet M2a Magnum, since February 2011, amid concerns that recipients of these types of devices are more likely to require revision surgery due to premature failure compared to patients who received hips made from other materials. On January 17, 2013, the FDA announced that it had proposed new regulations that, if adopted, would subject all-metal implants to greater regulatory scrutiny. The agency also advised recipients of metal-on-metal hip implants to undergo metal ion blood testing if they were experiencing symptoms of hip failure.
Recipients of the Biomet M2a Magnum who suffered serious complications, including metallosis, chronic pain, or early failure of the implant, may be entitled to compensation for medical bills, lost wages, pain and suffering, and other damages. Learn More about fling a Biomet hip lawsuit at Bernstein Liebhard LLP’s website. For additional information and a free case review, please call one our attorneys today at 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP